Abstract
We present the case of an 83-year-old patient who underwent cardiac surgery and developed postoperative non-occlusive mesenteric ischemia (NOMI), which was treated with a local intra-arterial papaverine and prostaglandin E1 infusion. After successful mesenteric reperfusion, a multiple organ dysfunction syndrome with severe cardiovascular failure developed. High norepinephrine dosages (1.09 µg/kg body weight/min) and catecholamine-related complications (tachycardiac atrial fibrillation) required initiation of supplementary argininevasopressin (AVP) infusion (4 U/h). AVP stabilized vasodilatory shock, ensured adequate gut perfusion pressure and had no adverse clinical or angiographic effects on restitution of gut integrity. In conclusion, after reperfusion of NOMI in this patient, adjunct AVP therapy combined with local vasodilator infusion was beneficial as a potentially life-saving vasopressor.
Zusammenfassung
Wir berichten über einen 83-jährigen Mann, der nach einem kardiochirurgischen Eingriff eine nichtokklusive mesenteriale Ischämie (NOMI) entwickelte, die mit einer lokalen intraarteriellen Infusion mit Papaverin und Prostaglandin E1 behandelt wurde. Nach erfolgreicher mesenterialer Reperfusion entwickelte sich ein Multiorgandysfunktionssyndrom mit schwerem Herzkreislaufversagen. Hohe Noradrenalindosen (1,09 µg/kgKG/min) und katecholamininduzierte Komplikationen (tachykardes Vorhofflimmern) erforderten eine zusätzliche Arginin-Vasopressin- (AVP-)Infusion. Arginin-Vasopressin stabilisierte den vasodilatorischen Schock, sicherte einen adäquaten Perfusionsdruck des Darms und hatte keine negativen klinischen oder angiographischen Auswirkungen auf die Erholung der Darmintegrität. Zusammenfassend erwies sich bei diesem Patienten nach Reperfusion einer NOMI AVP in Kombination mit Noradrenalin und lokaler Vasodilatatorinfusion als potenziell lebensrettender Vasopressor.
Similar content being viewed by others
References
Bone HG, Westphal M, Aken HC van (2002) Vasopressin – Not only good news! Crit Care Med 30:2604–2605
Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955
Doguet F, Litzler PY, Tamion F (2004) Changes in mesenteric vascular reactivity and inflammatory response after cardiopulmonary bypass in a rat model. Ann Thorac Surg 77:2130–2137
Dunser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319
Dunser MW, Wenzel V, Mayr AJ, Hasibeder W (2003) Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 63:237–256
Eker A, Malzac B, Teboul J, Jourdan J (1999) Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as treatment? Eur J Cardiothorac Surg 15:218–220
Ernst S, Luther B, Zimmermann N, Bohner H, Wilke R, Feindt P, Furst G (2003) Current diagnosis and therapy of non-occlusive mesenteric ischemia. Rofo 175:515–523
Giantomasso D di, May CN, Bellomo R (2002) Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804–1809
Harward TR, Brooks DL, Flynn TC, Seeger JM (1993) Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 18:459–469
Holmes CL, Walley KR (2004) Vasopressin in the ICU. Curr Opin Crit Care 10:442–448
Huwer H, Winning J, Straub U, Isringhaus H, Kalweit G (2004) Clinically diagnosed nonocclusive mesenteric ischemia after cardiopulmonary bypass: retrospective study. Vascular 12:114–120
Klempnauer J, Grothues F, Bektas H, Wahlers T (1997) Acute mesenteric ischemia following cardiac surgery. J Cardiovasc Surg 38:639–643
Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646–2650
Klotz S, Vestring T, Rotker J, Schmidt C, Scheld HH, Schmid C (2001) Diagnosis and treatment of nonocclusive ischemia after open heart surgery. Ann Thorac Surg 72:1583–1586
Lock G, Scholmerich J (1995) Non-occlusive mesenteric ischemia. Hepatogastroenterology 42:234–239
Malay MB, Ashton JL, Dahl K et al. (2004) Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 32:1327–1331
Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756–1763
Martinez MC, Vila JM, Aldasoro M, Medina P, Flor B, Lluch S (1994) Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br J Pharmacol 113:419–424
Morelli A, Rocco M, Conti G et al. (2004) Effects of terlipressin on systemic and regional hemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597–604
Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582
Schutz A, Eichinger W, Breuer M, Gansera B, Kemkes BM (1998) Acute mesenteric ischemia after open heart surgery. Angiology 48:267–273
Silva E, Backer D de, Creteur J, Vincent JL (1998) Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 26:1749–1758
Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P (2002) Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol 12:1179–1187
Westphal M, Freise H, Kehrel BE, Bone HG, Aken H van, Sielenkamper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194–200
Conflict of interest:
No information supplied.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luckner, G., Jochberger, S., Mayr, V.D. et al. Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia. Anaesthesist 55, 283–286 (2006). https://doi.org/10.1007/s00101-005-0958-3
Issue Date:
DOI: https://doi.org/10.1007/s00101-005-0958-3
Keywords
- Argininevasopressin infusion
- Non-occlusive mesenteric ischemia
- Vasodilatory shock
- Norepinephrine
- Multiple organ dysfunction syndrome